Trials / Completed
CompletedNCT00608946
Treatment With Copper in Patients With Mild Alzheimer´s Dementia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- University Hospital, Saarland · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The efficacy of 8 mg of copper daily regarding cognitive function, content of beta amyloid protein in the CSF and volumetric changes in the brain will be examined in a first double-blind, placebo-controlled human clinical trial conducted in 70 patients with mild Alzheimer´s dementia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | copper | intake of copper orotate 8 mg per day per os, once daily for one year, vs. placebo under observation of the cognitive status |
| DIETARY_SUPPLEMENT | placebo | placebo |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2007-08-01
- First posted
- 2008-02-06
- Last updated
- 2008-02-06
Source: ClinicalTrials.gov record NCT00608946. Inclusion in this directory is not an endorsement.